193 related articles for article (PubMed ID: 30064142)
1. Circulating α-Klotho Levels in Hemodialysis Patients and Their Relationship to Atherosclerosis.
Yu L; Kang L; Ren XZ; Diao ZL; Liu WH
Kidney Blood Press Res; 2018; 43(4):1174-1182. PubMed ID: 30064142
[TBL] [Abstract][Full Text] [Related]
2. Relationship of Serum Soluble Klotho Levels and Echocardiographic Parameters in Patients on Maintenance Hemodialysis.
Zhang AH; Guo WK; Yu L; Liu WH
Kidney Blood Press Res; 2019; 44(3):396-404. PubMed ID: 31079116
[TBL] [Abstract][Full Text] [Related]
3. [Plasma level of apelin and carotid atherosclerosis in maintenance hemodialysis patients].
Tang R; Wang R; Ao X; Cheng X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 42(6):617-622. PubMed ID: 28690216
[TBL] [Abstract][Full Text] [Related]
4. Influence of Residual Renal Function in Carotid Modeling as a Marker of Early Atherosclerosis in Dialysis Patients.
Rroji M; Spahia N; Seferi S; Barbullushi M; Spasovski G
Ther Apher Dial; 2017 Oct; 21(5):451-458. PubMed ID: 28714271
[TBL] [Abstract][Full Text] [Related]
5. Associations of sclerostin with carotid artery atherosclerosis and all-cause mortality in Chinese patients undergoing maintenance hemodialysis.
Chen A; Sun Y; Cui J; Zhao B; Wang H; Chen X; Mao Y
BMC Nephrol; 2018 Oct; 19(1):264. PubMed ID: 30314461
[TBL] [Abstract][Full Text] [Related]
6. Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4.
Seiler S; Rogacev KS; Roth HJ; Shafein P; Emrich I; Neuhaus S; Floege J; Fliser D; Heine GH
Clin J Am Soc Nephrol; 2014 Jun; 9(6):1049-58. PubMed ID: 24677555
[TBL] [Abstract][Full Text] [Related]
7. Soluble Klotho is not independently associated with cardiovascular disease in a population of dialysis patients.
Buiten MS; de Bie MK; Bouma-de Krijger A; van Dam B; Dekker FW; Jukema JW; Rabelink TJ; Rotmans JI
BMC Nephrol; 2014 Dec; 15():197. PubMed ID: 25495997
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast Growth Factor 23 and α-Klotho Protein Are Associated with Adverse Clinical Outcomes in Non-Dialysis CKD Patients.
Manou E; Thodis E; Arsos G; Pasadakis P; Panagoutsos S; Papadopoulou D; Papagianni A
Kidney Blood Press Res; 2020; 45(6):900-915. PubMed ID: 33040068
[TBL] [Abstract][Full Text] [Related]
9. FGF-23 levels are associated with vascular calcification, but not with atherosclerosis, in hemodialysis patients.
Turan MN; Kircelli F; Yaprak M; Sisman AR; Gungor O; Bayraktaroglu S; Ozkahya M; Asci G; Floege J; Ok E
Int Urol Nephrol; 2016 Apr; 48(4):609-17. PubMed ID: 26865177
[TBL] [Abstract][Full Text] [Related]
10. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients.
Peng Y; Liu H; Liu F; Ouyang L; Cheng M; Gao L; Pan F; Liu Y; Chen X; Li J
Nephrology (Carlton); 2008 Oct; 13(7):579-86. PubMed ID: 19161364
[TBL] [Abstract][Full Text] [Related]
11. Relationship between Serum Soluble Klotho Protein and Coronary Artery Calcification and Prognosis in Patients on Maintenance Hemodialysis.
Zheng S; Zheng Y; Jin L; Zhou Z; Li Z
Iran J Public Health; 2018 Apr; 47(4):510-518. PubMed ID: 29900135
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of atherosclerosis, arterial stiffness and related risk factors in chronic hemodialysis patients in Siriraj Hospital.
Rattanasompattikul M; Chanchairujira K; On-Ajyooth L; Chanchairujira T
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S117-24. PubMed ID: 21721437
[TBL] [Abstract][Full Text] [Related]
13. The relationship between asymptomatic atherosclerosis and hepcidin-25 in chronic kidney disease patients.
Mohamed ON; Mady AM; Sedik MM; Issa AS; Mohamed OM; Abdelhameed NI
Ann Saudi Med; 2023; 43(5):298-308. PubMed ID: 37805814
[TBL] [Abstract][Full Text] [Related]
14. Increased serum levels of GDF-15 associated with mortality and subclinical atherosclerosis in patients on maintenance hemodialysis.
Yilmaz H; Çelik HT; Gurel OM; Bilgic MA; Namuslu M; Bozkurt H; Ayyildiz A; Inan O; Bavbek N; Akcay A
Herz; 2015 May; 40 Suppl 3():305-12. PubMed ID: 25117302
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor-23 (FGF-23) / soluble Klotho protein (sKlotho) / sclerostin glycoprotein ratio disturbance is a novel risk factor for cardiovascular complications in ESRD patients receiving treatment with regular hemodialysis or hemodiafiltration.
Milovanova LY; Dobrosmyslov IA; Milovanov YS; Taranova MV; Kozlov VV; Milovanova SY; Kozevnikova EI
Ter Arkh; 2018 Jun; 90(6):48-54. PubMed ID: 30701904
[TBL] [Abstract][Full Text] [Related]
16. Low Serum Level of Klotho Is an Early Predictor of Atherosclerosis.
Keles N; Caliskan M; Dogan B; Keles NN; Kalcik M; Aksu F; Kostek O; Aung SM; Isbilen B; Oguz A
Tohoku J Exp Med; 2015 Sep; 237(1):17-23. PubMed ID: 26289053
[TBL] [Abstract][Full Text] [Related]
17. Impact of serum apolipoprotein A-IV as a marker of cardiovascular disease in maintenance hemodialysis patients.
Omori M; Watanabe M; Matsumoto K; Honda H; Hattori H; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):341-8. PubMed ID: 20609189
[TBL] [Abstract][Full Text] [Related]
18. Serum fetuin a in hemodialysis: a link between derangement of calcium-phosphorus homeostasis and progression of atherosclerosis?
Pertosa G; Simone S; Ciccone M; Porreca S; Zaza G; Dalfino G; Memoli B; Procino A; Bonomini M; Sirolli V; Castellano G; Gesualdo L; Ktena M; Schena FP; Grandaliano G
Am J Kidney Dis; 2009 Mar; 53(3):467-74. PubMed ID: 19167798
[TBL] [Abstract][Full Text] [Related]
19. The Association of Fibroblast Growth Factor 23 with Arterial Stiffness and Atherosclerosis in Patients with Autosomal Dominant Polycystic Kidney Disease.
Coban M; Inci A; Yılmaz U; Asilturk E
Kidney Blood Press Res; 2018; 43(4):1160-1173. PubMed ID: 30064143
[TBL] [Abstract][Full Text] [Related]
20. Common carotid artery intima-media thickness and atherosclerotic plaques in carotid bulb in patients with chronic kidney disease on hemodialysis: a case-control study.
Shakeri A; Abdi M; Khosroshahi HT; Fouladi RF
Pak J Biol Sci; 2011 Sep; 14(17):844-8. PubMed ID: 22590835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
